Phibro Animal Health Corporatio (PAHC) Stock Analysis
Range Bound setup
Healthcare · Drug Manufacturers - Specialty & Generic
Sell if holding. Multiple concerning factors at $31.76: Concentration risk — Geographic: United States (57.0%); Concentration risk — Product: Animal Health (74.0%).
Phibro Animal Health is a global animal health and mineral nutrition company marketing approximately 800 product lines in approximately 90 countries to approximately 4,500 customers. Three segments: Animal Health (74% of FY2025 net sales, $963M), Mineral Nutrition (20%), and... Read more
Sell if holding. Multiple concerning factors at $31.76: Concentration risk — Geographic: United States (57.0%); Concentration risk — Product: Animal Health (74.0%). Chart setup: RSI 41 mid-range, Bollinger mid-band. Score 5.8/10, moderate confidence.
Passes 7/9 gates (positive momentum, favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity 79d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.
Recent developments
updated 2026-06-09Recent Developments — Phibro Animal Health Corporatio
Latest news
- NEWS Phibro Animal Health Corp (PAHC) Shares Fall 3.3% -- GF Value Sa - GuruFocus — GuruFocus negative
- NEWS Phibro Animal Health’s (NASDAQ:PAHC) Q1 CY2026: Beats On Revenue - StockStory — StockStory positive
- NEWS Phibro Animal Health’s (NASDAQ:PAHC) Q1 CY2026: Beats On Revenue - FinancialContent — FinancialContent positive
- NEWS Phibro Animal Health's (PAHC) CEO Sold 21,120 Shares for $1.2 Million - The Motley Fool — The Motley Fool neutral
- NEWS Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway - TradingView — TradingView neutral
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHGeographicUnited States57%10-K Item 1: 'United States ... _57_| _% _| _57_| _% _| _59_| _%_'
- HIGHProductAnimal Health74%10-K Item 1: 'Animal Health ... _74_| _% _| _69_| _% _| _67_| _%_'
Material Events(8-K, last 90d)
- 2026-04-14Item 5.02LOWJoyce J. Lee resigned from Board of Directors effective April 15, 2026. Resignation was not the result of any disagreement with the Company on any matter relating to operations, policies or practices.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
10 dimensions · all in-band
Price Targets
Position Sizing
Analyst Consensus
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Multiple concerning factors at $31.76: Concentration risk — Geographic: United States (57.0%); Concentration risk — Product: Animal Health (74.0%). Chart setup: RSI 41 mid-range, Bollinger mid-band. Prior stop was $29.54. Score 5.8/10, moderate confidence.
Take-profit target: $39.67 (+24.9% upside). Prior stop was $29.54. Stop-loss: $29.54.
Concentration risk — Geographic: United States (57.0%); Concentration risk — Product: Animal Health (74.0%); Leverage penalty (D/E 2.2): -1.5.
Phibro Animal Health Corporatio trades at a P/E of 13.9 (forward 9.7). TrendMatrix value score: 8.5/10. Verdict: Sell.
10 analysts cover PAHC with a consensus score of 2.5/5. Average price target: $46.
What does Phibro Animal Health Corporatio do?Phibro Animal Health is a global animal health and mineral nutrition company marketing approximately 800 product lines...
Phibro Animal Health is a global animal health and mineral nutrition company marketing approximately 800 product lines in approximately 90 countries to approximately 4,500 customers. Three segments: Animal Health (74% of FY2025 net sales, $963M), Mineral Nutrition (20%), and Performance Products (6%); total revenue $1.296B. The US represented 57% of FY2025 net sales.